Literature DB >> 31009237

Curcumin-Synthetic Analogs Library Screening by Docking and Quantitative Structure-Activity Relationship Studies for AXL Tyrosine Kinase Inhibition in Cancers.

Fatima Ghrifi1, Loubna Allam1, Lakhlili Wiame1, Azeddine Ibrahimi1.   

Abstract

AXL is an important drug target for cancers. Two-dimensional quantitative structure-activity relationship (2D-QSAR) tests were performed to elucidate a relationship between molecular structures and the activity of a series of 400 curcumin derivatives subjected to AXL kinase by ATP competition in the catalytic site. The partial least square regression method implanted in molecular operating environment software was applied to develop QSAR models, which were further validated for statistical significance by internal and external validation. The best model has proven to be statistically robust with a good predictive correlation of R2 = 0.996 and a significant cross-validation correlation coefficient of q2 = 0.707. Docking analysis reveled that three curcumin derivatives have the best affinity for AXL and formed a hydrogen bond with the important amino acid residues in the binding pocket. As treated in this article, the docking studies and 2D-QSAR approach will pave the way for the development of new drugs while highlighting curcumin and its derivatives.

Entities:  

Keywords:  2D-QSAR; AXL kinase; internal and external validation; partial least square regression

Year:  2019        PMID: 31009237      PMCID: PMC6786334          DOI: 10.1089/cmb.2019.0052

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  34 in total

1.  Interactions of curcumin with the PfATP6 model and the implications for its antimalarial mechanism.

Authors:  Hong-Fang Ji; Liang Shen
Journal:  Bioorg Med Chem Lett       Date:  2009-03-18       Impact factor: 2.823

2.  Lead- and drug-like compounds: the rule-of-five revolution.

Authors:  Christopher A Lipinski
Journal:  Drug Discov Today Technol       Date:  2004-12

Review 3.  Axl-dependent signalling: a clinical update.

Authors:  Vyacheslav A Korshunov
Journal:  Clin Sci (Lond)       Date:  2012-04       Impact factor: 6.124

4.  Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.

Authors:  Akram Mohammadi; Amirhossein Sahebkar; Mehrdad Iranshahi; Maral Amini; Roshanak Khojasteh; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  Phytother Res       Date:  2012-05-21       Impact factor: 5.878

Review 5.  Multitargeting by curcumin as revealed by molecular interaction studies.

Authors:  Subash C Gupta; Sahdeo Prasad; Ji Hye Kim; Sridevi Patchva; Lauren J Webb; Indira K Priyadarsini; Bharat B Aggarwal
Journal:  Nat Prod Rep       Date:  2011-10-06       Impact factor: 13.423

6.  Quantitative structure-activity relationships of selective antagonists of glucagon receptor using QuaSAR descriptors.

Authors:  Palanivelu Manoj Kumar; Chandrabose Karthikeyan; Narayana Subbiah Hari Narayana Moorthy; Piyush Trivedi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-11       Impact factor: 1.645

7.  Ligand docking and binding site analysis with PyMOL and Autodock/Vina.

Authors:  Daniel Seeliger; Bert L de Groot
Journal:  J Comput Aided Mol Des       Date:  2010-04-17       Impact factor: 3.686

Review 8.  Antitumor, anti-invasion, and antimetastatic effects of curcumin.

Authors:  Girija Kuttan; Kuzhuvelil B Hari Kumar; Chandrasekharan Guruvayoorappan; Ramadasan Kuttan
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

9.  Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.

Authors:  Guang Liang; Lili Shao; Yi Wang; Chengguang Zhao; Yanhui Chu; Jian Xiao; Yu Zhao; Xiaokun Li; Shulin Yang
Journal:  Bioorg Med Chem       Date:  2008-11-01       Impact factor: 3.641

10.  Structural elucidation of the DFG-Asp in and DFG-Asp out states of TAM kinases and insight into the selectivity of their inhibitors.

Authors:  Abdellah Messoussi; Lucile Peyronnet; Clémence Feneyrolles; Gwénaël Chevé; Khalid Bougrin; Aziz Yasri
Journal:  Molecules       Date:  2014-10-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.